Core Viewpoint - The company has announced its 2025 "Quality Improvement and Efficiency Enhancement" action plan, focusing on enhancing operational quality, increasing investor returns, and accelerating the development of new productive forces [1][3][5]. Group 1: Enhancing Operational Quality - The company is committed to steady operations and strengthening strategic execution to improve operational quality and core competitiveness, while advancing digital transformation [1]. - The company has established a diversified brand matrix and omnichannel layout, optimizing its core product offerings to enhance brand, product, and technological strength [2]. - The main brand, "Polaire," focuses on consumer needs, launching innovative products in response to high-growth demands and trends in medical aesthetics [2]. Group 2: Increasing Investor Returns - The company emphasizes a stable profit distribution policy, having distributed a total of 1.81 billion yuan in cash dividends from 2017 to 2024, with annual dividends exceeding 30% of net profit [3]. - The company plans to distribute a cash dividend of 1.19 yuan per share, totaling approximately 468.90 million yuan, which represents 39.48% of the net profit for the first half of 2025 [4]. Group 3: Accelerating Development of New Productive Forces - The company is focused on technological innovation, establishing a complete innovation chain from basic research to clinical application, and enhancing its global R&D system [5]. - As of June 30, 2025, the company holds 124 national invention patents and has successfully applied various innovations in its product lines [5]. Group 4: Strengthening Investor Communication - The company is enhancing investor communication through various channels, including regular performance briefings and interactive platforms, to address investor concerns and improve understanding [6]. - The company has committed to high-quality information disclosure, continuously optimizing the content and transparency of its disclosures [6]. Group 5: Ensuring Compliance and Governance - The company is improving its internal control systems and governance structure to enhance decision-making and operational compliance [7]. - The company is focusing on the responsibilities of key personnel, ensuring they are well-informed about regulatory updates and enhancing their compliance awareness [8]. Group 6: Ongoing Evaluation and Commitment - The company will continue to evaluate the specific measures of the "Quality Improvement and Efficiency Enhancement" action plan and fulfill its disclosure obligations [8].
珀莱雅: 珀莱雅化妆品股份有限公司关于2025年度“提质增效重回报”行动方案进展的公告